Selected research
Market Outlook & Growth Opportunities
Global CBD Oil Market Outlook and Growth Opportunities 2026
Market perspective
The global CBD Oil market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.
The North America market for CBD Oil is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for CBD Oil is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for CBD Oil is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
In China, the CBD Oil market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Major global companies in the CBD Oil market include ENDOCA, NuLeaf Naturals, Medical Marijuana, Isodiol, IRIE CBD, Folium Biosciences, Elixinol, CBD American Shaman and Aurora Cannabis, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global CBD Oil market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of CBD Oil and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents CBD Oil sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the CBD Oil market size, projected growth trends, production technologies, key applications, and end-use industries.
CBD Oil Segment by Company
ENDOCA
NuLeaf Naturals
Medical Marijuana
Isodiol
IRIE CBD
Folium Biosciences
Elixinol
CBD American Shaman
Aurora Cannabis
CBD Oil Segment by Type
Marijuana-Derived CBD Oil Products
Hemp-Derived CBD Oil Products
CBD Oil Segment by Application
Fibromyalgia (FM)
Diabetes
Anxiety
Others
CBD Oil Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global CBD Oil status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions CBD Oil market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify CBD Oil significant trends, drivers, influence factors in global and regions.
6. To analyze CBD Oil competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global CBD Oil market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of CBD Oil and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of CBD Oil.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the CBD Oil market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global CBD Oil industry.
Chapter 3: Detailed analysis of CBD Oil manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of CBD Oil in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of CBD Oil in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.
More report detail
Tables and figures
Scope & coverage.
Types
- Marijuana-Derived CBD Oil Products
- Hemp-Derived CBD Oil Products
Applications
- Fibromyalgia (FM)
- Diabetes
- Anxiety
- Others
Companies covered
- ENDOCA
- NuLeaf Naturals
- Medical Marijuana
- Isodiol
- IRIE CBD
- Folium Biosciences
- Elixinol
- CBD American Shaman
- Aurora Cannabis
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global CBD Oil Sales Value (2021-2032)
- 1.2.2 Global CBD Oil Sales Volume (2021-2032)
- 1.2.3 Global CBD Oil Sales Average Price (2021-2032)
- 1.3 Assumptions and Limitations
- 1.4 Study Goals and Objectives
2 CBD Oil Market Dynamics
- 2.1 CBD Oil Industry Trends
- 2.2 CBD Oil Industry Drivers
- 2.3 CBD Oil Industry Opportunities and Challenges
- 2.4 CBD Oil Industry Restraints
3 CBD Oil Market by Company
- 3.1 Global CBD Oil Company Revenue Ranking in 2025
- 3.2 Global CBD Oil Revenue by Company (2021-2026)
- 3.3 Global CBD Oil Sales Volume by Company (2021-2026)
- 3.4 Global CBD Oil Average Price by Company (2021-2026)
- 3.5 Global CBD Oil Company Ranking (2024-2026)
- 3.6 Global CBD Oil Company Manufacturing Base and Headquarters
- 3.7 Global CBD Oil Company Product Type and Application
- 3.8 Global CBD Oil Company Establishment Date
- 3.9 Market Competitive Analysis
- 3.9.1 Global CBD Oil Market Concentration Ratio (CR5 and HHI)
- 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
- 3.9.3 2025 CBD Oil Tier 1, Tier 2, and Tier 3 Companies
- 3.10 Mergers and Acquisitions Expansion
4 CBD Oil Market by Type
- 4.1 CBD Oil Type Introduction
- 4.1.1 Marijuana-Derived CBD Oil Products
- 4.1.2 Hemp-Derived CBD Oil Products
- 4.2 Global CBD Oil Sales Volume by Type
- 4.2.1 Global CBD Oil Sales Volume by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global CBD Oil Sales Volume by Type (2021-2032)
- 4.2.3 Global CBD Oil Sales Volume Share by Type (2021-2032)
- 4.3 Global CBD Oil Sales Value by Type
- 4.3.1 Global CBD Oil Sales Value by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global CBD Oil Sales Value by Type (2021-2032)
- 4.3.3 Global CBD Oil Sales Value Share by Type (2021-2032)
5 CBD Oil Market by Application
- 5.1 CBD Oil Application Introduction
- 5.1.1 Fibromyalgia (FM)
- 5.1.2 Diabetes
- 5.1.3 Anxiety
- 5.1.4 Others
- 5.2 Global CBD Oil Sales Volume by Application
- 5.2.1 Global CBD Oil Sales Volume by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global CBD Oil Sales Volume by Application (2021-2032)
- 5.2.3 Global CBD Oil Sales Volume Share by Application (2021-2032)
- 5.3 Global CBD Oil Sales Value by Application
- 5.3.1 Global CBD Oil Sales Value by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global CBD Oil Sales Value by Application (2021-2032)
- 5.3.3 Global CBD Oil Sales Value Share by Application (2021-2032)
6 CBD Oil Regional Sales and Value Analysis
- 6.1 Global CBD Oil Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global CBD Oil Sales by Region (2021-2032)
- 6.2.1 Global CBD Oil Sales by Region: 2021-2026
- 6.2.2 Global CBD Oil Sales by Region (2027-2032)
- 6.3 Global CBD Oil Sales Value by Region: 2021 VS 2025 VS 2032
- 6.4 Global CBD Oil Sales Value by Region (2021-2032)
- 6.4.1 Global CBD Oil Sales Value by Region: 2021-2026
- 6.4.2 Global CBD Oil Sales Value by Region (2027-2032)
- 6.5 Global CBD Oil Market Price Analysis by Region (2021-2026)
- 6.6 North America
- 6.6.1 North America CBD Oil Sales Value (2021-2032)
- 6.6.2 North America CBD Oil Sales Value Share by Country, 2025 VS 2032
- 6.7 Europe
- 6.7.1 Europe CBD Oil Sales Value (2021-2032)
- 6.7.2 Europe CBD Oil Sales Value Share by Country, 2025 VS 2032
- 6.8 Asia-Pacific
- 6.8.1 Asia-Pacific CBD Oil Sales Value (2021-2032)
- 6.8.2 Asia-Pacific CBD Oil Sales Value Share by Country, 2025 VS 2032
- 6.9 South America
- 6.9.1 South America CBD Oil Sales Value (2021-2032)
- 6.9.2 South America CBD Oil Sales Value Share by Country, 2025 VS 2032
- 6.10 Middle East & Africa
- 6.10.1 Middle East & Africa CBD Oil Sales Value (2021-2032)
- 6.10.2 Middle East & Africa CBD Oil Sales Value Share by Country, 2025 VS 2032
7 CBD Oil Country-level Sales and Value Analysis
- 7.1 Global CBD Oil Sales by Country: 2021 VS 2025 VS 2032
- 7.2 Global CBD Oil Sales Value by Country: 2021 VS 2025 VS 2032
- 7.3 Global CBD Oil Sales by Country (2021-2032)
- 7.3.1 Global CBD Oil Sales by Country (2021-2026)
- 7.3.2 Global CBD Oil Sales by Country (2027-2032)
- 7.4 Global CBD Oil Sales Value by Country (2021-2032)
- 7.4.1 Global CBD Oil Sales Value by Country (2021-2026)
- 7.4.2 Global CBD Oil Sales Value by Country (2027-2032)
- 7.5 USA
- 7.5.1 USA CBD Oil Sales Value Growth Rate (2021-2032)
- 7.5.2 USA CBD Oil Sales Value Share by Type, 2025 VS 2032
- 7.5.3 USA CBD Oil Sales Value Share by Application, 2025 VS 2032
- 7.6 Canada
- 7.6.1 Canada CBD Oil Sales Value Growth Rate (2021-2032)
- 7.6.2 Canada CBD Oil Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Canada CBD Oil Sales Value Share by Application, 2025 VS 2032
- 7.7 Mexico
- 7.6.1 Mexico CBD Oil Sales Value Growth Rate (2021-2032)
- 7.6.2 Mexico CBD Oil Sales Value Share by Type, 2025 VS 2032
- 7.6.3 Mexico CBD Oil Sales Value Share by Application, 2025 VS 2032
- 7.8 Germany
- 7.8.1 Germany CBD Oil Sales Value Growth Rate (2021-2032)
- 7.8.2 Germany CBD Oil Sales Value Share by Type, 2025 VS 2032
- 7.8.3 Germany CBD Oil Sales Value Share by Application, 2025 VS 2032
- 7.9 France
- 7.9.1 France CBD Oil Sales Value Growth Rate (2021-2032)
- 7.9.2 France CBD Oil Sales Value Share by Type, 2025 VS 2032
- 7.9.3 France CBD Oil Sales Value Share by Application, 2025 VS 2032
- 7.10 U.K.
- 7.10.1 U.K. CBD Oil Sales Value Growth Rate (2021-2032)
- 7.10.2 U.K. CBD Oil Sales Value Share by Type, 2025 VS 2032
- 7.10.3 U.K. CBD Oil Sales Value Share by Application, 2025 VS 2032
- 7.11 Italy
- 7.11.1 Italy CBD Oil Sales Value Growth Rate (2021-2032)
- 7.11.2 Italy CBD Oil Sales Value Share by Type, 2025 VS 2032
- 7.11.3 Italy CBD Oil Sales Value Share by Application, 2025 VS 2032
- 7.12 Spain
- 7.12.1 Spain CBD Oil Sales Value Growth Rate (2021-2032)
- 7.12.2 Spain CBD Oil Sales Value Share by Type, 2025 VS 2032
- 7.12.3 Spain CBD Oil Sales Value Share by Application, 2025 VS 2032
- 7.13 Russia
- 7.13.1 Russia CBD Oil Sales Value Growth Rate (2021-2032)
- 7.13.2 Russia CBD Oil Sales Value Share by Type, 2025 VS 2032
- 7.13.3 Russia CBD Oil Sales Value Share by Application, 2025 VS 2032
- 7.14 Netherlands
- 7.14.1 Netherlands CBD Oil Sales Value Growth Rate (2021-2032)
- 7.14.2 Netherlands CBD Oil Sales Value Share by Type, 2025 VS 2032
- 7.14.3 Netherlands CBD Oil Sales Value Share by Application, 2025 VS 2032
- 7.15 Nordic Countries
- 7.15.1 Nordic Countries CBD Oil Sales Value Growth Rate (2021-2032)
- 7.15.2 Nordic Countries CBD Oil Sales Value Share by Type, 2025 VS 2032
- 7.15.3 Nordic Countries CBD Oil Sales Value Share by Application, 2025 VS 2032
- 7.16 China
- 7.16.1 China CBD Oil Sales Value Growth Rate (2021-2032)
- 7.16.2 China CBD Oil Sales Value Share by Type, 2025 VS 2032
- 7.16.3 China CBD Oil Sales Value Share by Application, 2025 VS 2032
- 7.17 Japan
- 7.17.1 Japan CBD Oil Sales Value Growth Rate (2021-2032)
- 7.17.2 Japan CBD Oil Sales Value Share by Type, 2025 VS 2032
- 7.17.3 Japan CBD Oil Sales Value Share by Application, 2025 VS 2032
- 7.18 South Korea
- 7.18.1 South Korea CBD Oil Sales Value Growth Rate (2021-2032)
- 7.18.2 South Korea CBD Oil Sales Value Share by Type, 2025 VS 2032
- 7.18.3 South Korea CBD Oil Sales Value Share by Application, 2025 VS 2032
- 7.19 India
- 7.19.1 India CBD Oil Sales Value Growth Rate (2021-2032)
- 7.19.2 India CBD Oil Sales Value Share by Type, 2025 VS 2032
- 7.19.3 India CBD Oil Sales Value Share by Application, 2025 VS 2032
- 7.20 Australia
- 7.20.1 Australia CBD Oil Sales Value Growth Rate (2021-2032)
- 7.20.2 Australia CBD Oil Sales Value Share by Type, 2025 VS 2032
- 7.20.3 Australia CBD Oil Sales Value Share by Application, 2025 VS 2032
- 7.21 Southeast Asia
- 7.21.1 Southeast Asia CBD Oil Sales Value Growth Rate (2021-2032)
- 7.21.2 Southeast Asia CBD Oil Sales Value Share by Type, 2025 VS 2032
- 7.21.3 Southeast Asia CBD Oil Sales Value Share by Application, 2025 VS 2032
- 7.22 Brazil
- 7.22.1 Brazil CBD Oil Sales Value Growth Rate (2021-2032)
- 7.22.2 Brazil CBD Oil Sales Value Share by Type, 2025 VS 2032
- 7.22.3 Brazil CBD Oil Sales Value Share by Application, 2025 VS 2032
- 7.23 Argentina
- 7.23.1 Argentina CBD Oil Sales Value Growth Rate (2021-2032)
- 7.23.2 Argentina CBD Oil Sales Value Share by Type, 2025 VS 2032
- 7.23.3 Argentina CBD Oil Sales Value Share by Application, 2025 VS 2032
- 7.24 Chile
- 7.24.1 Chile CBD Oil Sales Value Growth Rate (2021-2032)
- 7.24.2 Chile CBD Oil Sales Value Share by Type, 2025 VS 2032
- 7.24.3 Chile CBD Oil Sales Value Share by Application, 2025 VS 2032
- 7.25 Colombia
- 7.25.1 Colombia CBD Oil Sales Value Growth Rate (2021-2032)
- 7.25.2 Colombia CBD Oil Sales Value Share by Type, 2025 VS 2032
- 7.25.3 Colombia CBD Oil Sales Value Share by Application, 2025 VS 2032
- 7.26 Peru
- 7.26.1 Peru CBD Oil Sales Value Growth Rate (2021-2032)
- 7.26.2 Peru CBD Oil Sales Value Share by Type, 2025 VS 2032
- 7.26.3 Peru CBD Oil Sales Value Share by Application, 2025 VS 2032
- 7.27 Saudi Arabia
- 7.27.1 Saudi Arabia CBD Oil Sales Value Growth Rate (2021-2032)
- 7.27.2 Saudi Arabia CBD Oil Sales Value Share by Type, 2025 VS 2032
- 7.27.3 Saudi Arabia CBD Oil Sales Value Share by Application, 2025 VS 2032
- 7.28 Israel
- 7.28.1 Israel CBD Oil Sales Value Growth Rate (2021-2032)
- 7.28.2 Israel CBD Oil Sales Value Share by Type, 2025 VS 2032
- 7.28.3 Israel CBD Oil Sales Value Share by Application, 2025 VS 2032
- 7.29 UAE
- 7.29.1 UAE CBD Oil Sales Value Growth Rate (2021-2032)
- 7.29.2 UAE CBD Oil Sales Value Share by Type, 2025 VS 2032
- 7.29.3 UAE CBD Oil Sales Value Share by Application, 2025 VS 2032
- 7.30 Turkey
- 7.30.1 Turkey CBD Oil Sales Value Growth Rate (2021-2032)
- 7.30.2 Turkey CBD Oil Sales Value Share by Type, 2025 VS 2032
- 7.30.3 Turkey CBD Oil Sales Value Share by Application, 2025 VS 2032
- 7.31 Iran
- 7.31.1 Iran CBD Oil Sales Value Growth Rate (2021-2032)
- 7.31.2 Iran CBD Oil Sales Value Share by Type, 2025 VS 2032
- 7.31.3 Iran CBD Oil Sales Value Share by Application, 2025 VS 2032
- 7.32 Egypt
- 7.32.1 Egypt CBD Oil Sales Value Growth Rate (2021-2032)
- 7.32.2 Egypt CBD Oil Sales Value Share by Type, 2025 VS 2032
- 7.32.3 Egypt CBD Oil Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
- 8.1 ENDOCA
- 8.1.1 ENDOCA Company Information
- 8.1.2 ENDOCA Business Overview
- 8.1.3 ENDOCA CBD Oil Sales, Value and Gross Margin (2021-2026)
- 8.1.4 ENDOCA CBD Oil Product Portfolio
- 8.1.5 ENDOCA Recent Developments
- 8.2 NuLeaf Naturals
- 8.2.1 NuLeaf Naturals Company Information
- 8.2.2 NuLeaf Naturals Business Overview
- 8.2.3 NuLeaf Naturals CBD Oil Sales, Value and Gross Margin (2021-2026)
- 8.2.4 NuLeaf Naturals CBD Oil Product Portfolio
- 8.2.5 NuLeaf Naturals Recent Developments
- 8.3 Medical Marijuana
- 8.3.1 Medical Marijuana Company Information
- 8.3.2 Medical Marijuana Business Overview
- 8.3.3 Medical Marijuana CBD Oil Sales, Value and Gross Margin (2021-2026)
- 8.3.4 Medical Marijuana CBD Oil Product Portfolio
- 8.3.5 Medical Marijuana Recent Developments
- 8.4 Isodiol
- 8.4.1 Isodiol Company Information
- 8.4.2 Isodiol Business Overview
- 8.4.3 Isodiol CBD Oil Sales, Value and Gross Margin (2021-2026)
- 8.4.4 Isodiol CBD Oil Product Portfolio
- 8.4.5 Isodiol Recent Developments
- 8.5 IRIE CBD
- 8.5.1 IRIE CBD Company Information
- 8.5.2 IRIE CBD Business Overview
- 8.5.3 IRIE CBD CBD Oil Sales, Value and Gross Margin (2021-2026)
- 8.5.4 IRIE CBD CBD Oil Product Portfolio
- 8.5.5 IRIE CBD Recent Developments
- 8.6 Folium Biosciences
- 8.6.1 Folium Biosciences Company Information
- 8.6.2 Folium Biosciences Business Overview
- 8.6.3 Folium Biosciences CBD Oil Sales, Value and Gross Margin (2021-2026)
- 8.6.4 Folium Biosciences CBD Oil Product Portfolio
- 8.6.5 Folium Biosciences Recent Developments
- 8.7 Elixinol
- 8.7.1 Elixinol Company Information
- 8.7.2 Elixinol Business Overview
- 8.7.3 Elixinol CBD Oil Sales, Value and Gross Margin (2021-2026)
- 8.7.4 Elixinol CBD Oil Product Portfolio
- 8.7.5 Elixinol Recent Developments
- 8.8 CBD American Shaman
- 8.8.1 CBD American Shaman Company Information
- 8.8.2 CBD American Shaman Business Overview
- 8.8.3 CBD American Shaman CBD Oil Sales, Value and Gross Margin (2021-2026)
- 8.8.4 CBD American Shaman CBD Oil Product Portfolio
- 8.8.5 CBD American Shaman Recent Developments
- 8.9 Aurora Cannabis
- 8.9.1 Aurora Cannabis Company Information
- 8.9.2 Aurora Cannabis Business Overview
- 8.9.3 Aurora Cannabis CBD Oil Sales, Value and Gross Margin (2021-2026)
- 8.9.4 Aurora Cannabis CBD Oil Product Portfolio
- 8.9.5 Aurora Cannabis Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 CBD Oil Value Chain Analysis
- 9.1.1 CBD Oil Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 CBD Oil Sales Mode & Process
- 9.2 CBD Oil Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 CBD Oil Distributors
- 9.2.3 CBD Oil Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst